Skip to content

Exploring the Clinical and Mechanism of Xiaochaihu Decoction in the Treatment of Colorectal Cancer Metastasis Combined with Chronic Stress Based on the Theory of "Shaoyang as the Pivot"

Exploring the Clinical and Mechanism of Xiaochaihu Decoction in the Treatment of Colorectal Cancer Metastasis Combined with Chronic Stress Based on the Theory of "Shaoyang as the Pivot"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000074
Enrollment
Unknown
Registered
2026-01-13
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Intervention group:Intervention of Xiaochaihu Decoction formula granules
control group:Intervention of Chinese herbal placebo formula granules

Sponsors

The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed with colorectal cancer through pathology or cytology. 2) Patients with TNM staging of stage II, III, and IV; 3) Age range of 18-80 years old, expected survival period>6 months; 4) KPS = 60 points; 5) Voluntarily participate and sign an informed consent form, and cooperate with the follow-up. 6) If any of the following conditions are met: A. CPSS-14 Chinese Stress Perception Scale = 29 points; B. PHQ-9 Depression Screening Scale = 5 points; C. GAD-7 Self Rating Anxiety Scale = 5 points; D. The Traditional Chinese Medicine Syndrome Scale determines liver depression and spleen deficiency, as well as liver depression and qi stagnation.

Exclusion criteria

Exclusion criteria: 1) Merge primary tumors from other parts; 2) There are non tumor related serious diseases and functional disorders, active cerebrovascular disease, uncontrolled infections, and metabolic diseases in major organs such as the liver, kidneys, and heart; 3) Those who have received treatment with anti anxiety, depression, and antipsychotic drugs within six months.; 4) Individuals who are allergic to known components of traditional Chinese medicine used in the study; 5) Pregnant women, lactating women, and mentally ill patients; 6) Those who are currently participating or have participated in other drug clinical trials within the past 4 weeks.

Design outcomes

Primary

MeasureTime frame
Progression-free survival;

Secondary

MeasureTime frame
Overall survival;Quality of life;Traditional Chinese Medicine Syndrome Indicators;Immune function;The degree of emotional disorders in patients;Serum neurotransmitter;

Countries

China

Contacts

Public ContactYan Wang

The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine

yanwang@shutcm.edu.cn17717074405

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026